ArticleScientific reports2016

Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells.

Giovanna Talarico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.